Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-06-27

Clinical Trial Update: The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin Reactions [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the use of Silver Leaf Dressing to prevent radiotherapy-induced skin reactions in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silver Leaf Dressing

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED